Developer docs
API playgroundTry for free, no card

Search company profiles

Diamondback Drugs

Full company profile

uuid000os7z

Namestring
Diamondback Drugs
Company typeenum
Private
Founded yearint
2001
Descriptiontext

Diamondback Drugs operates as a veterinary compounding pharmacy serving the full spectrum of animal healthcare — companion pet owners, equine veterinarians and horse owners, zoos, aquariums, wildlife rehabilitators, deer ranchers, and research institutions. The company custom-formulates pharmaceuticals that are commercially unavailable, difficult to administer, or require species-specific dosing, offering delivery formats including transdermal gels, tiny tabs, ophthalmic suspensions, and flavored suspensions (e.g., peppermint, alfalfa, cherry). Its 46,000+ medication formulary and FDA-registered 503B outsourcing facility status differentiate it from traditional 503A compounders on quality and regulatory profile, supplemented by PCAB, LegitScript, and BBB certifications.

The technology layer centers on Blue Rabbit, a PIMS-integrated e-prescribing platform that connects veterinary practices to the company's formulary and supports prescription management, ordering, and home delivery for pet owners. Blue Rabbit functions as both a workflow tool for veterinary clinics and a direct-to-consumer channel, and is intended to make the pharmacy a single-vendor purchasing experience for both custom compounds and commercial medications, diets, and supplements. Distribution is omnichannel: direct B2B ordering with veterinary practices, DTC online pharmacy (wedgewood.pet), Blue Rabbit Home Delivery, and specialty channels for wildlife and equine segments.

Revenue is generated primarily through per-prescription sales of compounded medications at quote-based pricing, supplemented by subscription access to the Blue Rabbit platform for veterinary practices. The business shows active 2024 strategic activity — integration of Precision Equine Pharmacy (equine vertical build-out), launch of compounded molnupiravir for feline FIP, the Blue Rabbit platform introduction, and a CEO transition — alongside an Inc. Power Partner award in 2023. Note: the firmographic record lists Diamondback Drugs at 51–100 employees, while the operational data (40+ year compounding history, 503B facility, multi-vertical formulary, platform) is consistent with substantially larger scale; this discrepancy should be reconciled during diligence.

Short descriptiontext

Diamondback Drugs operates a veterinary compounding pharmacy with a 46,000+ medication formulary, an FDA-registered 503B outsourcing facility, and the Blue Rabbit PIMS-integrated e-prescribing and home-delivery platform, serving companion animal and equine practices, pet owners, zoos, and research institutions.

Ownership categoryenum
Headcount rangeband
51–100
akta.pro rankint
HeadquartersScottsdale, United States
HQ citystring
Scottsdale
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
veterinary compounding pharmacy, compounded pet medications, 503B outsourcing facility, PIMS-integrated e-prescribing, animal drug compounding
Industry3 codes
PRIMARYHLAMAIAD
Compounding Pharmacies (Veterinary)
Healthcare & Life Sciences/Veterinary & Animal Health/Veterinary Distribution & Retail (Wholesalers, Pharmacies)
SECONDARYHLAMAMAF
Veterinary Inventory, Pharmacy & Medication Management
SECONDARYHLAMAGAF
E‑prescribing, Pharmacy Ordering & Medication Management (Rx, Refills, Home Delivery Integrations)
Healthcare & Life Sciences/Veterinary & Animal Health/Animal Health Digital Platforms (Practice Mgmt, Tele-vet)
NAICS code1 code
  • Drugs and Druggists' Sundries Merchant Wholesalers42421
SIC code1 code
  • Pharmaceutical Preparations2834
Product category
Veterinary Pharmacy / Animal Pharmaceutical Compounding
Revenue model2 records
1Compounded Veterinary Medications
TypeOne Time License
Description

Sale of customized pharmaceutical preparations for animals including companion pets, equine, and wildlife. Revenue generated through prescription orders from veterinary practices and pet owners, utilizing a 503B outsourcing facility for compliant compounding.

wedgewood.com
2Blue Rabbit Platform Services
TypeSubscription Recurring
Description

Subscription-based access to PIMS-integrated e-prescribing platform enabling veterinary practices to manage prescriptions, order medications, and provide home delivery services to pet owners.

wedgewood.com
Marketing channels7 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Personnel, Supply Chain, Operations, Technology or R&D, Marketing or Sales, Infrastructure
Pricing details1 tier
1Quote-based pricing for compounded medications
ModelOtherBilling cadencePay-as-you-go
Notes

Pricing determined per prescription based on medication type, quantity, compounding requirements, and delivery format. No standard pricing tiers publicly available.

wedgewood.com
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

Diamondback Drugs (operating alongside Wedgewood Pharmacy) provides custom-compounded veterinary medications across companion animal, equine, and wildlife/exotic segments, sold on a per-prescription basis through the Blue Rabbit PIMS-integrated e-prescribing platform and direct-to-consumer online pharmacy. The company operates an FDA-registered 503B Outsourcing Facility for higher-quality compounded preparations and supports veterinary practices with home delivery for pet and horse owners. A formulary of 46,000+ veterinary medications spans transdermal gels, tiny tabs, ophthalmic suspensions/solutions, and flavored suspensions (including peppermint and alfalfa equine flavors).

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 3 values shown
  • 99% of veterinarians recognize Wedgewood brand
+2 more records
Product overview1 text field

Wedgewood (associated with Diamondback Drugs) operates as a veterinary pharmacy offering compounded pet medications through a platform-plus-modules architecture. The core offering includes veterinary compounding services and a 503B outsourcing facility, supported by the Blue Rabbit PIMS-integrated platform for e-prescribing and practice management. Additional modules include Blue Rabbit Home Delivery for pet owners and specialized equine pharmacy services (formerly Precision Equine Pharmacy). The formulary includes approximately 46,000 veterinary medications across various dosage forms.

Product and service6 records
1Veterinary Compounding Services
CategoryVeterinary pharmaceutical compounding
Description

Custom-compounded medications for companion animals (dogs, cats, avian), equine patients, and wildlife/exotic species across formats including transdermal gels, tiny tabs, ophthalmic suspensions/solutions, and flavored suspensions (e.g., peppermint, alfalfa). Available per veterinary prescription through the Blue Rabbit platform and direct-to-consumer online pharmacy.

2Blue Rabbit
CategoryVeterinary pharmacy software platform
Description

PIMS-integrated platform enabling veterinarians to prescribe custom compounds and commercial medications, diets, and supplements in one place. Includes e-prescribing, practice management integration, prescription management, and home delivery capabilities for pet and horse owners.

3503B Outsourcing Facility
CategoryVeterinary pharmaceutical manufacturing
Description

FDA-registered 503B outsourcing facility providing compounded veterinary medications under heightened cGMP quality and regulatory standards, supplying veterinary practices and hospitals with compliant preparations.

4Equine Pharmacy Services (Precision Equine Pharmacy)
CategoryEquine veterinary pharmacy
Description

Specialized equine pharmacy services offering horse-specific compounded medications and formulations including performance, pain management, and transdermal gel preparations with flavor options such as peppermint and alfalfa.

5Blue Rabbit Home Delivery
CategoryPrescription home delivery
Description

Direct-to-door prescription delivery service for pet and horse owners receiving compounded medications ordered through the Blue Rabbit platform or the Wedgewood Pet online pharmacy.

6Compounded Molnupiravir for FIP
CategoryCompounded veterinary medication
Description

Compounded molnupiravir preparation for the treatment of Feline Infectious Peritonitis (FIP) in cats, formulated through the veterinary compounding service line.

Scale indicator6 records

Each record includes

Type, Value, Description, Source

Partnership1 partner
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Precision Equine Pharmacy completed integration with Wedgewood in July 2024, combining specialized equine compounding expertise under the Wedgewood brand. This merger expanded Wedgewood's equine pharmacy capabilities and product offerings for horse owners and equine veterinarians.

Recent move5 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
1Wedgewood Pharmacy
TypeDirect peer
Description

The dominant North American veterinary compounding pharmacy; appears to be the same or sister operation to Diamondback Drugs based on the URL redirect pattern (diamondbackdrugs as a UTM source for wedgewood.com). Operates the Blue Rabbit PIMS-integrated platform, 503B Outsourcing Facility, and 46,000+ medication formulary referenced in the source data.

2Stokes Pharmacy
TypeEmerging player
Description

A 503B-registered compounding pharmacy serving human and veterinary patients with custom preparations and outsourcing capabilities. Comparable as a direct 503B/compounding competitor with regulatory parity and overlapping preparation modalities to those used in veterinary medicine.

TypeBroad incumbent
Description

Direct-to-consumer pet pharmacy and supplies retailer with a national prescription fulfillment footprint. Comparable as a competing D2C channel for compounded and commercial veterinary medications targeting pet owners — represents consumer-side competition to Wedgewood Pet Online Pharmacy.

TypeEmerging player
Description

A veterinary supply marketplace and procurement platform that aggregates ordering for independent practices. Comparable as a digital practice procurement layer and could be a substitute (or channel) for the Blue Rabbit ordering workflow at the practice level.

5Patterson Veterinary
TypeBroad incumbent
Description

A major distributor of veterinary supplies, equipment, and pharmacy products to companion-animal practices across the US. Comparable as a broad-line supplier serving the same veterinary practice buyer with pharmacy, consumables, and equipment under one commercial relationship.

TypeDirect peer
Description

A leading veterinary pharmacy and home delivery platform serving practices nationwide with e-prescribing and prescription management workflow. Direct overlap with the Blue Rabbit offering on B2B e-prescribing and home delivery modules serving the same veterinary practice customer.

TypeEmerging player
Description

Global leader in pharmaceutical compounding raw materials, semisolids, and equipment, with veterinary compounding as a meaningful growth line. Comparable as a competing compounding supply chain participant with veterinary segment exposure and shared regulatory backdrop (USP, GFI #256).

TypeBroad incumbent
Description

A long-established direct-to-consumer pet pharmacy retailer offering prescription and OTC medications with home delivery. Comparable as a competitor in the consumer-side channel and as a reference for scaled D2C pet pharmacy economics.

TypeEmerging player
Description

A pharmaceutical compounding supplier providing active ingredients, bases, and equipment to compounding pharmacies (human and veterinary). Comparable as an upstream compounding supplier with overlap in veterinary compounding workflows, though operating further up the value chain.

TypeBroad incumbent
Description

One of the largest US veterinary distributors and pharmacy services platforms, offering practice owners ordering, pharmacy, and inventory management at scale. Overlaps with Diamondback/Wedgewood's B2B practice channel and represents the incumbent distribution and pharmacy platform alternative to Blue Rabbit.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers2 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile4 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature2 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
No data
Compliance3 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Diamondback Drugs

Veterinary Pharmacy / Animal Pharmaceutical Compoundingdiamondbackdrugs.com

Diamondback Drugs operates a veterinary compounding pharmacy with a 46,000+ medication formulary, an FDA-registered 503B outsourcing facility, and the Blue Rabbit PIMS-integrated e-prescribing and home-delivery platform, serving companion animal and equine practices, pet owners, zoos, and research institutions.

What Diamondback Drugs does

Diamondback Drugs operates as a veterinary compounding pharmacy serving the full spectrum of animal healthcare — companion pet owners, equine veterinarians and horse owners, zoos, aquariums, wildlife rehabilitators, deer ranchers, and research institutions. The company custom-formulates pharmaceuticals that are commercially unavailable, difficult to administer, or require species-specific dosing, offering delivery formats including transdermal gels, tiny tabs, ophthalmic suspensions, and flavored suspensions (e.g., peppermint, alfalfa, cherry). Its 46,000+ medication formulary and FDA-registered 503B outsourcing facility status differentiate it from traditional 503A compounders on quality and regulatory profile, supplemented by PCAB, LegitScript, and BBB certifications.

The technology layer centers on Blue Rabbit, a PIMS-integrated e-prescribing platform that connects veterinary practices to the company's formulary and supports prescription management, ordering, and home delivery for pet owners. Blue Rabbit functions as both a workflow tool for veterinary clinics and a direct-to-consumer channel, and is intended to make the pharmacy a single-vendor purchasing experience for both custom compounds and commercial medications, diets, and supplements. Distribution is omnichannel: direct B2B ordering with veterinary practices, DTC online pharmacy (wedgewood.pet), Blue Rabbit Home Delivery, and specialty channels for wildlife and equine segments.

Revenue is generated primarily through per-prescription sales of compounded medications at quote-based pricing, supplemented by subscription access to the Blue Rabbit platform for veterinary practices. The business shows active 2024 strategic activity — integration of Precision Equine Pharmacy (equine vertical build-out), launch of compounded molnupiravir for feline FIP, the Blue Rabbit platform introduction, and a CEO transition — alongside an Inc. Power Partner award in 2023. Note: the firmographic record lists Diamondback Drugs at 51–100 employees, while the operational data (40+ year compounding history, 503B facility, multi-vertical formulary, platform) is consistent with substantially larger scale; this discrepancy should be reconciled during diligence.

Diamondback Drugs firmographics

Firmographics
Name
Diamondback Drugs
Website
https://diamondbackdrugs.com
Company type
Private
Founded year
2001
Headcount range
51–100 employees
Short description
Diamondback Drugs operates a veterinary compounding pharmacy with a 46,000+ medication formulary, an FDA-registered 503B outsourcing facility, and the Blue Rabbit PIMS-integrated e-prescribing and home-delivery platform, serving companion animal and equine practices, pet owners, zoos, and research institutions.
Ownership category
akta.pro rank

Diamondback Drugs industry classification

Industry
Product category
Veterinary Pharmacy / Animal Pharmaceutical Compounding
NAICS
Drugs and Druggists' Sundries Merchant Wholesalers (42421)
SIC
Pharmaceutical Preparations (2834)
akta.pro industry
PRIMARYHLAMAIAD
Compounding Pharmacies (Veterinary)
Healthcare & Life Sciences/Veterinary & Animal Health/Veterinary Distribution & Retail (Wholesalers, Pharmacies)
SECONDARYHLAMAMAF
Veterinary Inventory, Pharmacy & Medication Management
SECONDARYHLAMAGAF
E‑prescribing, Pharmacy Ordering & Medication Management (Rx, Refills, Home Delivery Integrations)
Healthcare & Life Sciences/Veterinary & Animal Health/Animal Health Digital Platforms (Practice Mgmt, Tele-vet)

Keywords

  • Veterinary compounding pharmacy
  • Compounded pet medications
  • 503B outsourcing facility
  • PIMS-integrated e-prescribing
  • Animal drug compounding

Where Diamondback Drugs is headquartered

Location

Headquarters

HQ city
Scottsdale
HQ country
United States
HQ region
North America

Offices1 record

Markets served

Diamondback Drugs business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Supply Chain, Operations, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

  1. Compounded Veterinary Medications: Sale of customized pharmaceutical preparations for animals including companion pets, equine, and wildlife. Revenue generated through prescription orders from veterinary practices and pet owners, utilizing a 503B outsourcing facility for compliant compounding.
  2. Blue Rabbit Platform Services: Subscription-based access to PIMS-integrated e-prescribing platform enabling veterinary practices to manage prescriptions, order medications, and provide home delivery services to pet owners.

Pricing tiers

ModelBillingPrice
OtherPay-as-you-goQuote-based pricing for compounded medications

Distribution channels3 records

Marketing channels7 records

Diamondback Drugs product offering

Product offering

Core offering

Diamondback Drugs (operating alongside Wedgewood Pharmacy) provides custom-compounded veterinary medications across companion animal, equine, and wildlife/exotic segments, sold on a per-prescription basis through the Blue Rabbit PIMS-integrated e-prescribing platform and direct-to-consumer online pharmacy. The company operates an FDA-registered 503B Outsourcing Facility for higher-quality compounded preparations and supports veterinary practices with home delivery for pet and horse owners. A formulary of 46,000+ veterinary medications spans transdermal gels, tiny tabs, ophthalmic suspensions/solutions, and flavored suspensions (including peppermint and alfalfa equine flavors).

Product overview

Wedgewood (associated with Diamondback Drugs) operates as a veterinary pharmacy offering compounded pet medications through a platform-plus-modules architecture. The core offering includes veterinary compounding services and a 503B outsourcing facility, supported by the Blue Rabbit PIMS-integrated platform for e-prescribing and practice management. Additional modules include Blue Rabbit Home Delivery for pet owners and specialized equine pharmacy services (formerly Precision Equine Pharmacy). The formulary includes approximately 46,000 veterinary medications across various dosage forms.

Differentiator

Problem solved

Functional benefit

Products and services

  • Veterinary Compounding Services Custom-compounded medications for companion animals (dogs, cats, avian), equine patients, and wildlife/exotic species across formats including transdermal gels, tiny tabs, ophthalmic suspensions/solutions, and flavored suspensions (e.g., peppermint, alfalfa). Available per veterinary prescription through the Blue Rabbit platform and direct-to-consumer online pharmacy.
  • Blue Rabbit PIMS-integrated platform enabling veterinarians to prescribe custom compounds and commercial medications, diets, and supplements in one place. Includes e-prescribing, practice management integration, prescription management, and home delivery capabilities for pet and horse owners.
  • 503B Outsourcing Facility FDA-registered 503B outsourcing facility providing compounded veterinary medications under heightened cGMP quality and regulatory standards, supplying veterinary practices and hospitals with compliant preparations.
  • Equine Pharmacy Services (Precision Equine Pharmacy) Specialized equine pharmacy services offering horse-specific compounded medications and formulations including performance, pain management, and transdermal gel preparations with flavor options such as peppermint and alfalfa.
  • Blue Rabbit Home Delivery Direct-to-door prescription delivery service for pet and horse owners receiving compounded medications ordered through the Blue Rabbit platform or the Wedgewood Pet online pharmacy.
  • Compounded Molnupiravir for FIP Compounded molnupiravir preparation for the treatment of Feline Infectious Peritonitis (FIP) in cats, formulated through the veterinary compounding service line.

Quantifiable outcome

  • 99% of veterinarians recognize Wedgewood brand
  • +2 more outcomes

Companies that use Diamondback Drugs

Customer profile

Named customers2 records

Segments4 records

Ideal customer profiles4 records

Diamondback Drugs technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature2 records

Diamondback Drugs partnerships and signals

Strategic signal

Partnerships

One partnership is on record.

  • Precision Equine PharmacycoreStrategic or Co-development PartnerPrecision Equine Pharmacy completed integration with Wedgewood in July 2024, combining specialized equine compounding expertise under the Wedgewood brand. This merger expanded Wedgewood's equine pharmacy capabilities and product offerings for horse owners and equine veterinarians.

Scale indicators6 records

Recent moves5 records

Expansion highlights5 records

Diamondback Drugs competitors and assessment

Company assessment

Direct peers

  • Wedgewood Pharmacy: The dominant North American veterinary compounding pharmacy; appears to be the same or sister operation to Diamondback Drugs based on the URL redirect pattern (diamondbackdrugs as a UTM source for wedgewood.com). Operates the Blue Rabbit PIMS-integrated platform, 503B Outsourcing Facility, and 46,000+ medication formulary referenced in the source data.
  • Vetsource: A leading veterinary pharmacy and home delivery platform serving practices nationwide with e-prescribing and prescription management workflow. Direct overlap with the Blue Rabbit offering on B2B e-prescribing and home delivery modules serving the same veterinary practice customer.

Emerging players

  • Stokes Pharmacy: A 503B-registered compounding pharmacy serving human and veterinary patients with custom preparations and outsourcing capabilities. Comparable as a direct 503B/compounding competitor with regulatory parity and overlapping preparation modalities to those used in veterinary medicine.
  • Vetcove: A veterinary supply marketplace and procurement platform that aggregates ordering for independent practices. Comparable as a digital practice procurement layer and could be a substitute (or channel) for the Blue Rabbit ordering workflow at the practice level.
  • Fagron: Global leader in pharmaceutical compounding raw materials, semisolids, and equipment, with veterinary compounding as a meaningful growth line. Comparable as a competing compounding supply chain participant with veterinary segment exposure and shared regulatory backdrop (USP, GFI #256).
  • Medisca: A pharmaceutical compounding supplier providing active ingredients, bases, and equipment to compounding pharmacies (human and veterinary). Comparable as an upstream compounding supplier with overlap in veterinary compounding workflows, though operating further up the value chain.

Broad incumbents

  • Chewy Pharmacy: Direct-to-consumer pet pharmacy and supplies retailer with a national prescription fulfillment footprint. Comparable as a competing D2C channel for compounded and commercial veterinary medications targeting pet owners — represents consumer-side competition to Wedgewood Pet Online Pharmacy.
  • Patterson Veterinary: A major distributor of veterinary supplies, equipment, and pharmacy products to companion-animal practices across the US. Comparable as a broad-line supplier serving the same veterinary practice buyer with pharmacy, consumables, and equipment under one commercial relationship.
  • 1-800-PetMeds (PetMeds): A long-established direct-to-consumer pet pharmacy retailer offering prescription and OTC medications with home delivery. Comparable as a competitor in the consumer-side channel and as a reference for scaled D2C pet pharmacy economics.
  • MWI Animal Health (Covetrus): One of the largest US veterinary distributors and pharmacy services platforms, offering practice owners ordering, pharmacy, and inventory management at scale. Overlaps with Diamondback/Wedgewood's B2B practice channel and represents the incumbent distribution and pharmacy platform alternative to Blue Rabbit.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights6 records

Customer concentration

Diamondback Drugs social profiles

Digital presence

Diamondback Drugs compliance and trust

Trust signal

Compliance3 records

Diamondback Drugs financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Diamondback Drugs leadership team

Management profile

Number of profiles

Diamondback Drugs funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Diamondback Drugs M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Diamondback Drugs

What does Diamondback Drugs do?

Diamondback Drugs (operating alongside Wedgewood Pharmacy) provides custom-compounded veterinary medications across companion animal, equine, and wildlife/exotic segments, sold on a per-prescription basis through the Blue Rabbit PIMS-integrated e-prescribing platform and direct-to-consumer online pharmacy. The company operates an FDA-registered 503B Outsourcing Facility for higher-quality compounded preparations and supports veterinary practices with home delivery for pet and horse owners. A formulary of 46,000+ veterinary medications spans transdermal gels, tiny tabs, ophthalmic suspensions/solutions, and flavored suspensions (including peppermint and alfalfa equine flavors).

When was Diamondback Drugs founded?

Diamondback Drugs was founded in 2001. It employs 51 to 100 people.

Where is Diamondback Drugs based?

Diamondback Drugs is headquartered in Scottsdale, United States, in the North America region.

How does Diamondback Drugs make money?

Two revenue lines are on record. Compounded Veterinary Medications are the primary driver. The others are blue Rabbit Platform Services.

Who are Diamondback Drugs's main competitors?

Direct peers on record are Wedgewood Pharmacy and Vetsource. Emerging players are Stokes Pharmacy, Vetcove, Fagron and Medisca. Broad incumbents are Chewy Pharmacy, Patterson Veterinary, 1-800-PetMeds (PetMeds) and MWI Animal Health (Covetrus).

Does Diamondback Drugs have an API?

No public API is recorded for Diamondback Drugs.

What industry is Diamondback Drugs in?

Diamondback Drugs's product category is Veterinary Pharmacy / Animal Pharmaceutical Compounding. Its primary akta.pro industry code is HLAMAIAD, Compounding Pharmacies (Veterinary), with a secondary code of HLAMAMAF, Veterinary Inventory, Pharmacy & Medication Management. Its NAICS code is 42421 and its SIC code is 2834.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
PR NewswireNorth America Vet Compounding Pharmacies Market is expected to increase from US$ 1.1 Bn in 2020 to over US$ 2.7 Bn by 2031Persistence Market Research released industry analysis projecting the North America vet compounding pharmacies market will grow from US$1.1 billion in 2020 to over US$2.7 billion by 2031, expanding at a CAGR of approximately 8.5%. Growth drivers include increased pet adoption, rising owner awareness, high costs of branded veterinary products, and preference for alternative dosage formulations. Key strategic moves in the sector include Wedgewood Pharmacy's 2018 merger with Diamondback Drugs to expand product portfolios and capture market share, while the U.S. dominates the regional market.PrwebDiamondback Drugs Integrates VPR Cloud into VetPrescriber, the Online E-Prescription Platform For VeterinariansDiamondback Drugs integrated VPR Cloud into its VetPrescriber e-prescription platform, making it the only compounding pharmacy with a fully integrated drug formulary. The integration automates prescription workflows with drug interaction checks and dosage calculators, and a 60-day free trial is offered to VetPrescriber customers.PrwebDiamondback Drugs Now a Recommended Veterinary Pharmacy of The Veterinary CooperativeDiamondback Drugs, a veterinary compounding pharmacy, announced a partnership with The Veterinary Cooperative (TVC) as a recommended vendor. TVC, with 2,900 active clinic members, will offer Diamondback's customized pharmaceuticals through VetPrescriber. TVC aims to grow to 5,000 members.